Artelo Biosciences, INC Form 4 insider transactions

Gregory D. Gorgas, CEO of Artelo Biosciences, amends and reprices several stock option grants as part of a company-wide offer.

Director Reyes Gregory amended the terms of several stock options in Artelo Biosciences, including repricing and revesting, as part of a company-wide offer.

Director Douglas Blayney amends stock option grants in Artelo Biosciences, reflecting repricing and revesting offer.

Director Connie Matsui reports adjustments to stock options following a repricing and revesting offer by Artelo Biosciences.